Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Subtyping of sarcomas based on pathway enrichment scores in bulk and single cell transcriptomes. | J Transl Med | 2022 | 35093080 | PubTator, text mining | PubMed |
| Relation between expression of hMLH1 and p53 mRNA genes, in the feces of patients with colorectal carcinoma. Cross-sectional study. | Ann Med Surg (Lond) | 2022 | 35079371 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Co-Mutations Identifies Cooperating Mechanisms of Tumorigenesis. | Cancers (Basel) | 2022 | 35053577 | PubTator, text mining | PubMed |
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial. | Lancet Oncol | 2022 | 35033226 | PubTator, text mining | PubMed |
| Incidental germline findings during molecular profiling of tumor tissues for precision oncology: molecular survey and methodological obstacles. | J Transl Med | 2022 | 35033101 | PubTator, text mining | PubMed |
| N6-methyladenosine modification regulates imatinib resistance of gastrointestinal stromal tumor by enhancing the expression of multidrug transporter MRP1. | Cancer Lett | 2022 | 35032557 | PubTator, text mining | PubMed |
| DNA damage in preimplantation embryos and gametes: specification, clinical relevance and repair strategies. | Hum Reprod Update | 2022 | 35021196 | PubTator, text mining | PubMed |
| Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines. | J Cancer Res Clin Oncol | 2022 | 35020044 | PubTator, text mining | PubMed |
| The insertion and dysregulation of transposable elements in osteosarcoma and their association with patient event-free survival. | Sci Rep | 2022 | 35013466 | PubTator, text mining | PubMed |
| Genetic Analysis Reveals the Prognostic Significance of the DNA Mismatch Repair Gene MSH2 in Advanced Prostate Cancer. | Cancers (Basel) | 2022 | 35008387 | PubTator, text mining | PubMed |
| Microsatellite Instability, Epstein-Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer. | Cancers (Basel) | 2022 | 35008382 | PubTator, text mining | PubMed |
| Do non-pathogenic variants of DNA mismatch repair genes modify neurofibroma load in neurofibromatosis type 1? | Childs Nerv Syst | 2022 | 34997843 | PubTator, text mining | PubMed |
| COL17A1 germline variant p.Ser1029Ala and mucosal malignant melanoma: An autopsy study. | Mol Clin Oncol | 2022 | 34987801 | PubTator, text mining | PubMed |
| Nuclear magnetic resonance reveals a two hairpin equilibrium near the 3'-splice site of influenza A segment 7 mRNA that can be shifted by oligonucleotides. | RNA | 2022 | 34983822 | PubTator, text mining | PubMed |
| Clinical efficiency of simultaneous CNV-seq and whole-exome sequencing for testing fetal structural anomalies. | J Transl Med | 2022 | 34980134 | PubTator, text mining | PubMed |
| Advancing genomic technologies and clinical awareness accelerates discovery of disease-associated tandem repeat sequences. | Genome Res | 2022 | 34965938 | PubTator, text mining | PubMed |
| Genomic analyses of the metastasis-derived prostate cancer cell lines LNCaP, VCaP, and PC3-AR. | Prostate | 2022 | 34951700 | PubTator, text mining | PubMed |
| Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer. | Cancer Discov | 2022 | 34933901 | PubTator, text mining | PubMed |
| The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study. | Blood Adv | 2022 | 34933330 | PubTator, text mining | PubMed |
| A Double-Pronged Sword: XJB-5-131 Is a Suppressor of Somatic Instability and Toxicity in Huntington's Disease. | J Huntingtons Dis | 2022 | 34924397 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=38